Asundexian Bayer 10mg Granules, BAY 2433334
21174
Phase 1 small_molecule active
Quick answer
Asundexian Bayer 10mg Granules, BAY 2433334 for Prevention of thromboembolic events is a Phase 1 program (small_molecule) at Bayer AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer AG
- Indication
- Prevention of thromboembolic events
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active